NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > News > News for COVID-19

COVID-19 News

Oxford study reveals public attitudes to vaccine roll-out programmes

23 February 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

An international study led by University of Oxford health economists and political scientists has found that there is much greater consistency in public attitudes across a number of countries about who should be prioritised for COVID-19 vaccination than there is in national policies. The study, ... READ MORE

Oxford study shows high level of readmissions and death after COVID-19 discharge

22 February 2021 · Listed under COVID-19, Translational Data Science

Some 30% of patients discharged after being admitted to hospital with community-acquired COVID-19 had been readmitted or died within 60 days, a study by Oxford researchers has shown. In a paper published in the European Journal of Public Health, they found that, as anticipated, rates of ... READ MORE

Oxford-led technology to help those at high risk from Covid-19

16 February 2021 · Listed under COVID-19, Multimorbidity and Long-Term Conditions, Translational Data Science

Image link to post

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus. Research led by Professor Julia Hippisley-Cox in the ... READ MORE

Oxford University extends COVID-19 vaccine study to children

15 February 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

The University of Oxford coronavirus vaccine team has launched the first study to assess the safety and immune responses in children and young adults of their ChAdOx1 nCoV-19 vaccine. The study, which will be conducted with partner sites in London, Southampton and Bristol, builds on previous ... READ MORE

Tocilizumab found to reduce deaths in hospitalised COVID-19patients

11 February 2021 · Listed under COVID-19, Translational Data Science

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that the anti-inflammatory drug, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. The trial, which received core funding from the NIHR Oxford ... READ MORE

Lateral flow devices found to be useful in screening OUH staff for coronavirus

11 February 2021 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Image link to post

Infection prevention and control clinicians and researchers at Oxford University Hospitals (OUH) have been outlining the OUH’s experience of deploying self-administered home-based lateral flow testing of its staff. In a letter published in the Journal of Infection, they said that 46,503 ... READ MORE

Drug trial that could improve respiratory recovery from COVID-19 under way

10 February 2021 · Listed under COVID-19, Respiratory Medicine

A clinical trial has begun to test whether the drug Almitrine can help people who are seriously ill with COVID-19 recover from the disease. Oxford University Hospitals NHS Foundation Trust is one of three centres taking part in the trial. Patients suffering from COVID-19 pneumonia often ... READ MORE

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

8 February 2021 · Listed under COVID-19, Respiratory Medicine

Image link to post

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found. The STOIC study found that inhaled budesonide given to patients with COVID-19 ... READ MORE

Oxford coronavirus vaccine shows sustained protection between doses

2 February 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

Researchers at the University of Oxford have revealed that the efficacy of the Oxford/AstraZeneca coronavirus vaccine is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22 to up to 90 days post-vaccination. In their findings, published in ... READ MORE

Fewer colorectal cancer diagnoses reported during COVID-19

29 January 2021 · Listed under COVID-19, Translational Data Science

University of Oxford researchers from the UK Colorectal Cancer Intelligence Hub have been investigating how the diagnosis and treatment of colorectal cancer patients has been affected by the COVID-19 pandemic. The NIHR Oxford BRC-supported researchers at the Nuffield Department of Population ... READ MORE

Lateral flow devices detect most infectious COVID-19 cases, study shows

22 January 2021 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Image link to post

Researchers from the University of Oxford, working with Public Health England, have used NHS Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most ... READ MORE

COVID-19 ‘matching service’ increased public involvement in research, HRA finds

20 January 2021 · Listed under COVID-19, Partnerships for Health, Wealth and Innovation, Patient and Public Involvement and Engagement

The Health Research Authority (HRA) has found that levels of public involvement in COVID-19 research increased following the introduction of a public involvement matching service, in a report published last week. A group of public contributors from the NIHR Oxford Biomedical Research Centre took ... READ MORE

Oxford study confirms medium-term impact of COVID-19

11 January 2021 · Listed under COVID-19, Imaging

Image link to post

A study looking at the longer-term impact of COVID-19 has found that a significant proportion of COVID-19 patients discharged from hospital reported symptoms of breathlessness, fatigue and depression and had limited exercise capacity several weeks after leaving hospital. The University of ... READ MORE

Oxford COVID-19 vaccinations begin

4 January 2021 · Listed under COVID-19, Life-saving Vaccines

Image link to post

The NHS has launched the roll-out of the new Oxford AstraZeneca coronavirus vaccine, with patients at Oxford University Hospitals NHS Foundation Trust (OUH) the very first to get the life-saving jab. Among the first to be vaccinated was Prof Andrew Pollard, the Oxford BRC investigator who has ... READ MORE

IBD treatments do not increase susceptibility to COVID-19, study finds

23 December 2020 · Listed under COVID-19, Inflammation across Tissues

Research by Oxford scientists has shown that rates of COVID-19 infection are not increased in patients with inflammatory bowel disease (IBD) who are being treated with the drugs infliximab or vedolizumab. The study data suggest there is no reason for treatment with these drugs to be ... READ MORE

Trial finds no benefit from azithromycin in hospitalised COVID-19 patients

14 December 2020 · Listed under COVID-19, Translational Data Science

Image link to post

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found no convincing evidence that that the widely used antibiotic azithromycin has any meaningful clinical benefits for patients who have been hospitalised with COVID-19. Azithromycin was regarded a ... READ MORE

AI test rules out a COVID-19 diagnosis within one hour in A&E

14 December 2020 · Listed under COVID-19, Translational Data Science

Image link to post

An artificial intelligence test has been shown to be able to rapidly screen patients arriving in emergency departments for COVID-19, using clinical information routinely available within the first hour of coming to hospital. Results of the CURIAL study, published in The Lancet Digital Health, ... READ MORE

Peer-reviewed results of phase 3 Oxford coronavirus vaccine trial demonstrate efficacy

8 December 2020 · Listed under COVID-19, Life-saving Vaccines

Image link to post

The vaccine against SARS-CoV-2 developed by researchers from the University of Oxford and AstraZeneca is safe and effective according to the peer-reviewed findings of the phase 3 trial. The pooled analysis of the trial across two different dose regimens resulted in an average efficacy of 70.4%; ... READ MORE

Hidden lung damage from COVID-19 revealed in new study

1 December 2020 · Listed under COVID-19, Imaging, Translational Data Science

Early findings from a study into longer-term damage in patients recovering from COVID-19 suggest that cutting-edge scanning techniques may detect previously unseen lung damage. The research by the universities of Oxford and Sheffield is the first in Europe to use hyperpolarised Xenon gas with MRI ... READ MORE

Oxford University breakthrough on global COVID-19 vaccine

23 November 2020 · Listed under COVID-19, Life-saving Vaccines

Image link to post

The University of Oxford, in collaboration with AstraZeneca plc, has announced interim trial data from its Phase III trials that shows its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 and offers a high level of protection. The interim analysis indicates that the ... READ MORE

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre